CN Patent

CN119345359A — 用于膀胱癌的新辅助疗法

Assigned to Photocure ASA · Expires 2025-01-24 · 1y expired

What this patent protects

本发明涉及用于排期进行膀胱切除术的膀胱癌患者中膀胱癌的新辅助疗法以及实施这种新辅助疗法的方法。具体地，本发明涉及包括5‑ALA己酯(HAL)或其药学上可接受的盐的组合物，用于排期进行膀胱切除术的膀胱癌患者的膀胱癌的新辅助疗法，该疗法包括将所述组合物滴注入所述患者的膀胱中并使所述膀胱内部暴露于光。

USPTO Abstract

本发明涉及用于排期进行膀胱切除术的膀胱癌患者中膀胱癌的新辅助疗法以及实施这种新辅助疗法的方法。具体地，本发明涉及包括5‑ALA己酯(HAL)或其药学上可接受的盐的组合物，用于排期进行膀胱切除术的膀胱癌患者的膀胱癌的新辅助疗法，该疗法包括将所述组合物滴注入所述患者的膀胱中并使所述膀胱内部暴露于光。

Drugs covered by this patent

Patent Metadata

Patent number
CN119345359A
Jurisdiction
CN
Classification
—
Expires
2025-01-24
Drug substance claim
No
Drug product claim
No
Assignee
Photocure ASA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.